Management of vasopressor induced ischemia.

Area of Science:

• Critical Care Medicine
• Vascular Surgery
• Pharmacology

Background:

• Vasopressors are vital for managing shock but carry a risk of inducing limb ischemia.
• Digital necrosis is a serious complication of vasopressor therapy, necessitating careful management.

Purpose of the Study:

• To evaluate patients with vasopressor-induced limb ischemia.
• To identify and recommend management options to prevent progression or minimize morbidity of digital necrosis.

Main Methods:

• Literature review of pressor-induced limb ischemia.
• Retrospective review of patient cases at a tertiary referral center.
• Development of tiered management guidelines.

Main Results:

• Thirty-six patients were analyzed, with 72% requiring multiple vasopressors.
• Common indications for vasopressors included septic shock (52.7%) and cardiogenic shock (16.7%).
• Management followed a tiered approach (Phase 1: 19%, Phase 2: 8.3%, Phase 3: 50%, Phase 4: 5.6%), with a 13.9% acute mortality rate.

Conclusions:

• Vasopressor therapy poses a risk of digital ischemia and necrosis.
• Early recognition and a structured, tiered management strategy are key to minimizing morbidity.
• This approach respects the "life over limb" paradigm and can yield acceptable outcomes.